The fact that our study demonstrates the low gene expression of the γ-secretase complex may argue against the therapeutic potential of γ-secretase inhibitors in MYCN-amplified NB tumors, which indeed demands further investigation. This evidence concerns the gene MYCN and neuroblastoma.